A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
Clinical trial NCT02516774 · WITHDRAWN
Trial details
- NCT number
- NCT02516774
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.